Page 5 - இரும்பு மரம் மருந்துகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Ladies and gentlemen, thank you for standing by, and welcome to the Ironwood Pharmaceuticals Fourth Quarter and Full Year 2020 Investor Update Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Meredith Kaya. Thank you. Please go ahead. Meredith Kaya Vice President, Investor Relations and Corporate Communications Good morning, and thanks for joining us for our fourth quarter and full year 2020 investor update. Our press release crossed the wire this morning and can be found on our website. Today s call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. The discussion of these statements and risk factors is available on the current Safe Harbor statement slide as well as under the heading Risk Factors in our quarterly report on Form 10-Q for the quarter ended September 30, 2020 and in our future SEC fili

Mike shetzlineMark mallonGina consylmanMichael shetzlineTom mccourtMartin austerMeredith kayaThomas mccourtIronwood pharmaceuticals fourth quarterIronwood pharmaceuticals incCorporate communicationsHead of drug developmentCredit suisseFull yearUpdate conferenceInvestor relations